TB Research

Critical assessment of infants born to mothers with drug resistant tuberculosis

Marian Loveday, Neel R. Gandhi, Palwasha Khan, Grant Theron, Sindisiwe Hlangu, Kerry Holloway, Sunitha Chotoo, Nalini Singh, et al. (9 authors)

EClinicalMedicine · 2024-09

Abstract

Background: There have been no detailed descriptions of infants born to mothers treated for drug resistant TB in pregnancy. Critical case history assessment is important to identify risks and guide clinical practice. Methods: transmission to the infant, and to describe the clinical presentation and disease trajectories observed in infants diagnosed with TB. Findings: transmission from non-maternal sources also contributed to TB development in infants. Interpretation: Infants born to mothers with MDR/RR-TB are at greatest risk if maternal adherence to MDR/RR-TB treatment or antiretroviral therapy (ART) is sub-optimal. In a high TB incidence setting, infants are also at risk of non-maternal household and community transmission. Ensuring maternal TB diagnosis and appropriate treatment, together with adequate TB screening and prevention in all babies born to mothers or households with TB will minimise the risk of infant TB disease development. Funding: South African Medical Research Council.

MeSH terms

  • Medicine
  • Tuberculosis
  • Pregnancy
  • Drug
  • Drug resistant tuberculosis
  • Pediatrics
  • Clinical Practice
  • Intensive care medicine